N4 Pharma Share Chat (N4P)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
N4 Pharma	LSE:N4P	London	Ordinary Share	GB00BYW8QM32	ORD 0.4P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.10p	-1.18%	8.35p	8.30p	8.40p	8.45p	8.15p	8.45p	764,868	14:32:15

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-1.9	-1.3	-	8.47

N4 Pharma Share Discussion Threads

Showing 5551 to 5571 of 5575 messages

Chat Pages: 223 222 221 220 219 218 217 216 215 214 213 212 Older

Date	Subject	Author	Discuss
15/2/2019 14:00	We are in the bottom of the previous accumulation range currently. Im topping up little bits here. Have some 7p buys set too.https://twitter.com/Unic0rnCharts/status/1094648649563471879?s=19	mypanic	Read Full Thread Reply
15/2/2019 13:56	I can see that there is money to be made trading this as its volatile. Question is, what point to enter. Risky as could be stuck with worthless stock.	jimbobaroony	Read Full Thread Reply
15/2/2019 13:35	I see it’s all going swimmingly post the fund raising! Yes I know hugh, you have inside information that 20 deals are about to be signed and beloved Nigel thinks everything is going wonderfully well.....but strangely it appears the market doesn’t believe you! Shocking really as you are so well informed 😉...	nobbygnome	Read Full Thread Reply
14/2/2019 14:45	10k max now at 8.3p	dave4545	Read Full Thread Reply
14/2/2019 14:43	Lets be realistic, before the placing people were jumping over each other to pay 13-14p It's a lot better value now at 8.3p but as you say it's also been below 5p too last year	dave4545	Read Full Thread Reply
14/2/2019 14:42	50k max from 250k	dave4545	Read Full Thread Reply
14/2/2019 13:58	Well you're a braver man than me! Has made a nice recovery from below 5p to the current 9.5p. Let's hope N4 doesn't continue to drift down and eat into your profits.	dplewis1	Read Full Thread Reply
14/2/2019 13:39	Back onboard at 8.3p.......bought MTFB at 6p this morning after dplewis1 post sold at 9p.............having a punt here with the profit Thanks dplewis1 for the heads up....	thaiflyer1	Read Full Thread Reply
14/2/2019 13:15	Can buy 250k online at 8.364p Considering the placing was only a few days ago at 10p are the placing Vendors taking a loss on the stock they did not shift ?	dave4545	Read Full Thread Reply
14/2/2019 07:13	Prime example over at MTFB this morning. Negative response from the FDA on their drug and all of a sudden they are staring down the barrel. The dangers of binary bets laid bare unfortunately for those holders.	dplewis1	Read Full Thread Reply
13/2/2019 23:32	Fully agree, still fairly early days and although results to date are promising we have to be prepared it could go sour, hence the risk is comparible with the reward if successful. I love the concept, the business model and to some extent the handling of the generics division. I will stay invested if the results from Adelaide come back positive but unfortunately will have to move on if the efficacy of the cytolytic vaccine isn’t improved when using Nuvec. To me this test is much more important than the a Medlmmune decision.	featherby81	Read Full Thread Reply
13/2/2019 23:21	All very interesting and let’s hope everything goes smoothly. But we are a long way off having a viable product. Remember Slidanfil! That failure can’t be ignored.	jimbobaroony	Read Full Thread Reply
13/2/2019 23:14	Small piece from the June 17 RNS, just to clear up any confusion that may occur. Animals were dosed once with 50, 150, 400 or 900 mg/kg nanoparticles, and then observed for 14 days. Clinical observations, body weights and food consumption were recorded, blood plasma samples were analysed for clinical pathology and selected common target organs were examined microscopically. The nanoparticles did not cause any systemic toxicity and all organs examined microscopically were normal, including at the highest dose, which is likely to be many times in excess of the concentrations that might be administered to humans. While there was some mild to moderate inflammation observed at the injection sites at all doses, these were non-specific and generally indicative of local inflammation. According to the board certified pathologist used in the study, these were similar to that which would be expected following implantation of a medical device or as a result of injecting a vaccine and would almost certainly resolve over time. In conclusion, a single subcutaneous administration of the nuvec® nanoparticles to rats did not cause any toxicological effects considered likely to be of long term concern.	featherby81	Read Full Thread Reply
13/2/2019 21:56	Nobbygnome, pure speculation and scare mongering. Look at what we know and what is probable and the picture is substantially brighter than you would have people believe. As I said before, time will tell and there should be no shortage of news and updates from N4 this year.	tankerton	Read Full Thread Reply
13/2/2019 20:24	As I said, zero credibility. His ‘inside information’ before resulted in a massive decline in the share price when the inevitable failure arrived. To make one mistake is understandable... to make exactly the same mistake again is madness..... The company is now a one trick pony and therefore, at high risk of complete failure. Just say some adverse reaction is seen to the particles in an animal model; then it would be all over bar the shouting (probably from hugh 😆)!	nobbygnome	Read Full Thread Reply
13/2/2019 20:00	What we do now know is that N4 will be more in the public domain as a result of Allan Heys speech at the Bionow conference today. Looking forward to feedback.	tankerton	Read Full Thread Reply
13/2/2019 19:37	You're talking to yourself you complete lunatic! Possibly one of the funniest things I've ever seen on a share chat though to be fair.	dplewis1	Read Full Thread Reply
13/2/2019 19:16	Oh and by the way:- dplewis113 Feb '19 - 18:53 - 1682 of 1683 (Filtered)	hughwilson	Read Full Thread Reply
13/2/2019 18:53	Yup.. he's been saying the same twaddle about japan since last Feb. This from the 23rd: "Today is N4P's last day in Japan. I don't envisage Nigel coming back empty handed so we are looking probably at a number of news releases over the next few minutes/days/weeks." This time next year Rodney..	dplewis1	Read Full Thread Reply
13/2/2019 18:46	I’ll give him credit, he’s persistent..	featherby81	Read Full Thread Reply
13/2/2019 18:41	As for evidence, read the RNS`s or the Allenby report. N4 intend to sign a production agreement this year.	tankerton	Read Full Thread Reply

Chat Pages: 223 222 221 220 219 218 217 216 215 214 213 212 Older

Your Recent History

LSE

N4P

N4 Pharma

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.